The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Fibrinogen Concentrate-Global Market Insights and Sales Trends 2025
Synopsis
The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc.
The global Fibrinogen Concentrate market size is expected to reach US$ 2207.6 million by 2029, growing at a CAGR of 15.5% from 2023 to 2029. The market is mainly driven by the significant applications of Fibrinogen Concentrate in various end use industries. The expanding demands from the Surgical Procedures, Congenital Fibrinogen Deficiency and Others,, are propelling Fibrinogen Concentrate market. Human Fibrinogen Concentrate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue ratios in 2019 are 52.52%, 20.36% and 10.02% respectively.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fibrinogen Concentrate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fibrinogen Concentrate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fibrinogen Concentrate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fibrinogen Concentrate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fibrinogen Concentrate covered in this report include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical and Octapharma, etc.
The global Fibrinogen Concentrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
LFB
Shanghai RAAS
Boya
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
Octapharma
Global Fibrinogen Concentrate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fibrinogen Concentrate market, Segment by Type:
Human Fibrinogen Concentrate
Others
Global Fibrinogen Concentrate market, by Application
Surgical Procedures
Congenital Fibrinogen Deficiency
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Fibrinogen Concentrate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Fibrinogen Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc.
The global Fibrinogen Concentrate market size is expected to reach US$ 2207.6 million by 2029, growing at a CAGR of 15.5% from 2023 to 2029. The market is mainly driven by the significant applications of Fibrinogen Concentrate in various end use industries. The expanding demands from the Surgical Procedures, Congenital Fibrinogen Deficiency and Others,, are propelling Fibrinogen Concentrate market. Human Fibrinogen Concentrate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue ratios in 2019 are 52.52%, 20.36% and 10.02% respectively.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fibrinogen Concentrate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fibrinogen Concentrate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fibrinogen Concentrate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fibrinogen Concentrate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fibrinogen Concentrate covered in this report include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical and Octapharma, etc.
The global Fibrinogen Concentrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
LFB
Shanghai RAAS
Boya
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
Octapharma
Global Fibrinogen Concentrate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fibrinogen Concentrate market, Segment by Type:
Human Fibrinogen Concentrate
Others
Global Fibrinogen Concentrate market, by Application
Surgical Procedures
Congenital Fibrinogen Deficiency
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Fibrinogen Concentrate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Fibrinogen Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Fibrinogen Concentrate Market Overview
1.1 Fibrinogen Concentrate Product Overview
1.2 Fibrinogen Concentrate Market Segment by Type
1.2.1 Human Fibrinogen Concentrate
1.2.2 Others
1.3 Global Fibrinogen Concentrate Market Size by Type
1.3.1 Global Fibrinogen Concentrate Market Size Overview by Type (2018-2029)
1.3.2 Global Fibrinogen Concentrate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Fibrinogen Concentrate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Fibrinogen Concentrate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Fibrinogen Concentrate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Fibrinogen Concentrate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Fibrinogen Concentrate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Fibrinogen Concentrate Sales Breakdown by Type (2018-2023)
2 Global Fibrinogen Concentrate Market Competition by Company
2.1 Global Top Players by Fibrinogen Concentrate Sales (2018-2023)
2.2 Global Top Players by Fibrinogen Concentrate Revenue (2018-2023)
2.3 Global Top Players by Fibrinogen Concentrate Price (2018-2023)
2.4 Global Top Manufacturers Fibrinogen Concentrate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Fibrinogen Concentrate Market Competitive Situation and Trends
2.5.1 Fibrinogen Concentrate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Fibrinogen Concentrate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fibrinogen Concentrate as of 2022)
2.7 Date of Key Manufacturers Enter into Fibrinogen Concentrate Market
2.8 Key Manufacturers Fibrinogen Concentrate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Fibrinogen Concentrate Status and Outlook by Region
3.1 Global Fibrinogen Concentrate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Fibrinogen Concentrate Historic Market Size by Region
3.2.1 Global Fibrinogen Concentrate Sales in Volume by Region (2018-2023)
3.2.2 Global Fibrinogen Concentrate Sales in Value by Region (2018-2023)
3.2.3 Global Fibrinogen Concentrate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Fibrinogen Concentrate Forecasted Market Size by Region
3.3.1 Global Fibrinogen Concentrate Sales in Volume by Region (2024-2029)
3.3.2 Global Fibrinogen Concentrate Sales in Value by Region (2024-2029)
3.3.3 Global Fibrinogen Concentrate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Fibrinogen Concentrate by Application
4.1 Fibrinogen Concentrate Market Segment by Application
4.1.1 Surgical Procedures
4.1.2 Congenital Fibrinogen Deficiency
4.1.3 Others
4.2 Global Fibrinogen Concentrate Market Size by Application
4.2.1 Global Fibrinogen Concentrate Market Size Overview by Application (2018-2029)
4.2.2 Global Fibrinogen Concentrate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Fibrinogen Concentrate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Fibrinogen Concentrate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Fibrinogen Concentrate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Fibrinogen Concentrate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Fibrinogen Concentrate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Fibrinogen Concentrate Sales Breakdown by Application (2018-2023)
5 North America Fibrinogen Concentrate by Country
5.1 North America Fibrinogen Concentrate Historic Market Size by Country
5.1.1 North America Fibrinogen Concentrate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Fibrinogen Concentrate Sales in Volume by Country (2018-2023)
5.1.3 North America Fibrinogen Concentrate Sales in Value by Country (2018-2023)
5.2 North America Fibrinogen Concentrate Forecasted Market Size by Country
5.2.1 North America Fibrinogen Concentrate Sales in Volume by Country (2024-2029)
5.2.2 North America Fibrinogen Concentrate Sales in Value by Country (2024-2029)
6 Europe Fibrinogen Concentrate by Country
6.1 Europe Fibrinogen Concentrate Historic Market Size by Country
6.1.1 Europe Fibrinogen Concentrate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Fibrinogen Concentrate Sales in Volume by Country (2018-2023)
6.1.3 Europe Fibrinogen Concentrate Sales in Value by Country (2018-2023)
6.2 Europe Fibrinogen Concentrate Forecasted Market Size by Country
6.2.1 Europe Fibrinogen Concentrate Sales in Volume by Country (2024-2029)
6.2.2 Europe Fibrinogen Concentrate Sales in Value by Country (2024-2029)
7 Asia-Pacific Fibrinogen Concentrate by Region
7.1 Asia-Pacific Fibrinogen Concentrate Historic Market Size by Region
7.1.1 Asia-Pacific Fibrinogen Concentrate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Fibrinogen Concentrate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Fibrinogen Concentrate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Fibrinogen Concentrate Forecasted Market Size by Region
7.2.1 Asia-Pacific Fibrinogen Concentrate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Fibrinogen Concentrate Sales in Value by Region (2024-2029)
8 Latin America Fibrinogen Concentrate by Country
8.1 Latin America Fibrinogen Concentrate Historic Market Size by Country
8.1.1 Latin America Fibrinogen Concentrate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Fibrinogen Concentrate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Fibrinogen Concentrate Sales in Value by Country (2018-2023)
8.2 Latin America Fibrinogen Concentrate Forecasted Market Size by Country
8.2.1 Latin America Fibrinogen Concentrate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Fibrinogen Concentrate Sales in Value by Country (2024-2029)
9 Middle East and Africa Fibrinogen Concentrate by Country
9.1 Middle East and Africa Fibrinogen Concentrate Historic Market Size by Country
9.1.1 Middle East and Africa Fibrinogen Concentrate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Fibrinogen Concentrate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Fibrinogen Concentrate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Fibrinogen Concentrate Forecasted Market Size by Country
9.2.1 Middle East and Africa Fibrinogen Concentrate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Fibrinogen Concentrate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL Behring
10.1.1 CSL Behring Company Information
10.1.2 CSL Behring Introduction and Business Overview
10.1.3 CSL Behring Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CSL Behring Fibrinogen Concentrate Products Offered
10.1.5 CSL Behring Recent Development
10.2 LFB
10.2.1 LFB Company Information
10.2.2 LFB Introduction and Business Overview
10.2.3 LFB Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 LFB Fibrinogen Concentrate Products Offered
10.2.5 LFB Recent Development
10.3 Shanghai RAAS
10.3.1 Shanghai RAAS Company Information
10.3.2 Shanghai RAAS Introduction and Business Overview
10.3.3 Shanghai RAAS Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Shanghai RAAS Fibrinogen Concentrate Products Offered
10.3.5 Shanghai RAAS Recent Development
10.4 Boya
10.4.1 Boya Company Information
10.4.2 Boya Introduction and Business Overview
10.4.3 Boya Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boya Fibrinogen Concentrate Products Offered
10.4.5 Boya Recent Development
10.5 Hualan Biological Engineering
10.5.1 Hualan Biological Engineering Company Information
10.5.2 Hualan Biological Engineering Introduction and Business Overview
10.5.3 Hualan Biological Engineering Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hualan Biological Engineering Fibrinogen Concentrate Products Offered
10.5.5 Hualan Biological Engineering Recent Development
10.6 Harbin Pacific Biopharmaceutical
10.6.1 Harbin Pacific Biopharmaceutical Company Information
10.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
10.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Products Offered
10.6.5 Harbin Pacific Biopharmaceutical Recent Development
10.7 Greencross
10.7.1 Greencross Company Information
10.7.2 Greencross Introduction and Business Overview
10.7.3 Greencross Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Greencross Fibrinogen Concentrate Products Offered
10.7.5 Greencross Recent Development
10.8 Shanghai XinXing Medical
10.8.1 Shanghai XinXing Medical Company Information
10.8.2 Shanghai XinXing Medical Introduction and Business Overview
10.8.3 Shanghai XinXing Medical Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Shanghai XinXing Medical Fibrinogen Concentrate Products Offered
10.8.5 Shanghai XinXing Medical Recent Development
10.9 Octapharma
10.9.1 Octapharma Company Information
10.9.2 Octapharma Introduction and Business Overview
10.9.3 Octapharma Fibrinogen Concentrate Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Octapharma Fibrinogen Concentrate Products Offered
10.9.5 Octapharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Fibrinogen Concentrate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Fibrinogen Concentrate Industrial Chain Analysis
11.4 Fibrinogen Concentrate Market Dynamics
11.4.1 Fibrinogen Concentrate Industry Trends
11.4.2 Fibrinogen Concentrate Market Drivers
11.4.3 Fibrinogen Concentrate Market Challenges
11.4.4 Fibrinogen Concentrate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Fibrinogen Concentrate Distributors
12.3 Fibrinogen Concentrate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
